SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-246077
Filing Date
2022-09-16
Accepted
2022-09-16 08:58:56
Documents
18
Period of Report
2022-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d360011d8k.htm   iXBRL 8-K 42816
2 EX-1.1 d360011dex11.htm EX-1.1 195408
3 EX-4.1 d360011dex41.htm EX-4.1 81898
4 EX-4.2 d360011dex42.htm EX-4.2 89189
5 EX-4.3 d360011dex43.htm EX-4.3 102311
6 EX-99.1 d360011dex991.htm EX-99.1 7788
7 EX-99.2 d360011dex992.htm EX-99.2 7287
  Complete submission text file 0001193125-22-246077.txt   785559

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA bntc-20220912.xsd EX-101.SCH 2894
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20220912_lab.xml EX-101.LAB 17237
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20220912_pre.xml EX-101.PRE 10838
12 EXTRACTED XBRL INSTANCE DOCUMENT d360011d8k_htm.xml XML 3212
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 221247037
SIC: 2834 Pharmaceutical Preparations